Euro
USD
British Pound
NULL
Product Description
Vanucizumab (ANGPT2/VEGFA) Antibody, Monoclonal | 10-665 | ProSci
Host: N/A
Reactivity: N/A
Homology: N/A
Immunogen: Humanized / ANGPT2/VEGFA [Homo sapiens],
Research Area: Drug Analogues
Tested Application: N/A
Application: N/A
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: >95%
Clonality: Monoclonal
Clone: N/A
Isotype: VH-C-kappa-CH2-CH3_V-lambda-CH1_H-GAMMA-1_L-kappa
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS buffer pH7.5
Concentration: N/A
Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚C for 1-2 weeks. Store at -20 ˚C for 12 months. Store at -80 ˚C for long term storage.
Alternate Name: RG-7221, RG7221, RO5520985
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Vanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.
